Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Go back to Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights| (NASDAQ: CADL) | Delayed: 9.26 +0.95 (11.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.31 | 52 Week High | $ | |||
| Open | $8.41 | 52 Week Low | $ | |||
| Day High | $9.26 | P/E | N/A | |||
| Day Low | $8.39 | EPS | $ | |||
| Volume | 1,197,428 | |||||

